Back
Amicus Therapeutics Stock Price Chart
Free 23-page book shares my #1 indicator to use
Here's the 23-page free book.
Buy
53
FOLD
Amicus Therapeutics
Last Price:
11.30
Seasonality Move:
-7.74%
7 Day Trial
ALL ACCESS PASS
$
7
10 minutes on Tuesday - $1,270 by Friday?
Click here to discover how this "odd" trade could double your money each week.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FOLD is experiencing buying pressure, which is a positive indicator for future bullish movement.
Amicus Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 11.17 | Buy |
| 20-day SMA: | 11.38 | Sell |
| 50-day SMA: | 11.02 | Buy |
| 200-day SMA: | 11.43 | Sell |
| 8-day EMA: | 11.19 | Buy |
| 20-day EMA: | 11.27 | Buy |
| 50-day EMA: | 11.07 | Buy |
| 200-day EMA: | 11.15 | Buy |
Amicus Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 51.25 | Buy |
| Chaikin Money Flow: | 3413042 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (11.17 - 11.75) | Sell |
| Bollinger Bands (100): | (9.74 - 11.24) | Buy |
Amicus Therapeutics Technical Analysis
| Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Amicus Therapeutics Stock
Is Amicus Therapeutics Stock a Buy?
- Amicus Therapeutics share price is 11.29 while FOLD 8-day simple moving average is 11.17, which is a Buy signal.
- The stock price of FOLD is 11.29 while Amicus Therapeutics 20-day SMA is 11.38, which makes it a Sell.
- Amicus Therapeutics 50-day simple moving average is 11.02 while FOLD share price is 11.29, making it a Buy technically.
- FOLD stock price is 11.29 and Amicus Therapeutics 200-day simple moving average is 11.43, creating a Sell signal.
FOLD Technical Analysis vs Fundamental Analysis
Buy
53
Amicus Therapeutics (FOLD)
is a Buy
Is Amicus Therapeutics a Buy or a Sell?
-
Amicus Therapeutics stock is rated a Buy
The current Amicus Therapeutics [FOLD] share price is $11.29. The Score for FOLD is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
Amicus Therapeutics Stock Info
Market Cap:
3.35B
Price in USD:
11.29
Share Volume:
4.06M
Amicus Therapeutics 52-Week Range
52-Week High:
14.57
52-Week Low:
9.02
Buy
53
Amicus Therapeutics (FOLD)
is a Buy
Amicus Therapeutics Share Price Forecast
-
What is the Amicus Therapeutics stock price today?
The Amicus Therapeutics stock price is 11.29 USD today. -
Will FOLD stock go up or go down?
Amicus Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Amicus Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Amicus Therapeutics is not overvalued.
Is Amicus Therapeutics Stock a Buy?
- Amicus Therapeutics share price is 11.29 while FOLD 8-day exponential moving average is 11.19, which is a Buy signal.
- The stock price of FOLD is 11.29 while Amicus Therapeutics 20-day EMA is 11.27, which makes it a Buy.
- Amicus Therapeutics 50-day exponential moving average is 11.07 while FOLD share price is 11.29, making it a Buy technically.
- FOLD stock price is 11.29 and Amicus Therapeutics 200-day simple moving average is 11.15, creating a Buy signal.
Fundamental Analysis of Amicus Therapeutics
Is Amicus Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.13 per share, an increase next quarter of $0.06 per share, an increase this year of $0.51 per share, and an increase next year of $0.29 per share.
Technical Analysis of Amicus Therapeutics
Should I short Amicus Therapeutics stock?
- FOLD Moving Average Covergence Divergence (MACD) indicator is -0.01, suggesting Amicus Therapeutics is a Sell
- Amicus Therapeutics Relative Strength Index (RSI) is 51.25, which suggest Amicus Therapeutics is overbought
- The Bollinger Bands (25) for Amicus Therapeutics is (11.17 - 11.75), which suggest Amicus Therapeutics is a Buy
- The Bollinger Bands (100) for Amicus Therapeutics is (9.74 - 11.24), which suggest Amicus Therapeutics is a Buy
* Amicus Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.